A research-driven pharmaceutical business, Eirgen Pharma specialises in the development, production, and distribution of a wide array of high potency oral dose medicine for both human and veterinary use. Their success in producing cancer chemotherapy drugs gave them a reputation for industry excellence and enabled them to form strong partnerships with leading pharmaceutical companies. In 2015, OPKO Health family of companies acquired Eirgen Pharma.
The multi award winning company was co-founded by Patsy Carney and Tom Brennan, both having significant experience in the pharmaceutical industry.
For their first year, the company incubated at Propelor’s Incubation Centre, availing of business planning support, sounding board advice, and international networking opportunities.
Still based in Waterford, Eirgen now serves patients in over 60 countries around the world, including major markets such as the United States, Europe, and Japan.
“Propelor has very highly qualified and experienced business consultants in the areas of finance, marketing and business planning who set you up to the next level of startup professionalism, with great facilities and great resources.
Tom Brennan, Co-Founder, Eirgen Pharma
